MGMTP140K gene-modified cells are safe and confer chemoprotection in phase I/II glioblastoma trial May 26, 2011
Genasense does not improve survival of dacarbazine-treated patients with melanoma in phase III trial May 25, 2011
Nexavar plus standard chemotherapy improves progression-free survival of patients with breast cancer May 24, 2011
RSS